secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001437749-24-015131
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health appoints Linda Stacy as PFO; Q1 dividend $0.12; $40M net debt; no GAAP results disclosed
--------------------------------------------------------------------------------

- Linda Stacy appointed Principal Financial Officer effective May 7, 2024; retains roles as PAAO and Secretary.
- Quarterly cash dividend of $0.12/share declared, payable July 15, 2024 to holders of record June 28, 2024.
- Q1 2024 returned $18M to stockholders via dividends and share repurchases; $4M invested in innovation.
- Net debt ~$40M; available liquidity includes $23M line of credit and $56M delayed draw term facility.
- Press release provides no GAAP revenue or EPS figures; CEO cites upcoming AI features and expanded product suite.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774924015131/0001437749-24-015131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774924015131/nrc20240506_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-015131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer